{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:27:05Z","timestamp":1788532025615,"version":"build-2803163510"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:p>\n                    The incidence of IgA nephropathy (IgAN) is increasing, and some observational studies reported the potential correlation of polycystic ovary syndrome (PCOS) with the risk of IgAN. We performed a bidirectional Mendelian randomization analysis to determine the causal relationship between PCOS and IgAN. Single nucleotide polymorphisms (SNPs) associated with PCOS were acquired from 2 genome-wide association studies (GWAS) (Finngen_R9 dataset: 1424 PCOS cases, 392,423 controls; PCOS summary statistics dataset: 10,074 PCOS cases, 103,164 controls). The outcome was defined as IgAN, based on the ebi-a-GCST90018866 dataset (15,587 IgAN cases and 462,197 healthy controls). Inverse-variance weighted (IVW), sensitivity, and reverse Mendelian randomization analyses were conducted to determine causal relationships between PCOS and IgAN. The FinnGen database identified 3 qualified SNPs, and showed no significant association between PCOS and IgAN, as revealed by the IVW method [odds ratio (OR)\u2005=\u20051.4405, 95% confidence interval (CI):0.9907\u20132.0939,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.05581]. The PCOS summary statistics dataset identified 8 qualified SNPs, and the results showed no significant association between PCOS and IgAN, as revealed by the IVW method (OR\u2005=\u20051.1187, 95% CI:0.5448\u20132.2972,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.75988). Evidence from the reverse Mendelian randomization indicated that IgAN did not increase the risk of PCOS in the FinnGen database (IVW: OR\u2005=\u20051.0473, 95% CI:0.9871\u20131.1112,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.1253) and PCOS summary statistics (IVW: OR\u2005=\u20051.021, 95% CI:0.9861\u20131.0572,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.24157). Bidirectional Mendelian randomization analysis did not provide evidence supporting a causal relationship between PCOS and IgAN. However, the limited number of instrumental SNPs may constrain the statistical power to detect modest effects, and further studies are needed to explore this association.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048704","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:00:29Z","timestamp":1778896829000},"page":"e48704","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Bidirectional Mendelian randomization study reveals no causal association between polycystic ovary syndrome and IgA nephropathy"],"prefix":"10.1097","volume":"105","author":[{"given":"Xia","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Second Affiliated Hospital of Jianghan University, Wuhan, Hubei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Second People\u2019s Hospital of Fuyang City, Fuyang, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyi","family":"Chai","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Wuhan Pulmonary Hospital, Wuhan, Hubei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8336-4253","authenticated-orcid":false,"given":"Xiulan","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Second Affiliated Hospital of Jianghan University, Wuhan, Hubei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260904","doi-asserted-by":"crossref","first-page":"104754","DOI":"10.1016\/j.ebiom.2023.104754","article-title":"Polycystic ovary syndrome: deciphering mechanisms to facilitate management and treatment.","volume":"94","year":"2023","journal-title":"Ebiomedicine"},{"key":"R2-20260904","first-page":"100494","article-title":"Changes in the prevalence of polycystic ovary syndrome in China over the past decade.","volume":"25","author":"Yang","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"R3-20260904","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/humrep\/deaa371","article-title":"Measuring the global disease burden of polycystic ovary syndrome in 194 countries: global Burden of Disease Study 2017.","volume":"36","author":"Liu","year":"2021","journal-title":"Hum Reprod"},{"key":"R4-20260904","doi-asserted-by":"crossref","first-page":"1337562","DOI":"10.3389\/fendo.2024.1337562","article-title":"Investigating the causal impact of polycystic ovary syndrome on gestational diabetes mellitus: a two-sample Mendelian randomization study.","volume":"15","author":"Guixue","year":"2024","journal-title":"Front Endocrinol"},{"key":"R5-20260904","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/ije\/dyz113","article-title":"Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study.","volume":"48","author":"Harris","year":"2019","journal-title":"Int J Epidemiol"},{"key":"R6-20260904","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ajog.2021.03.020","article-title":"Polycystic ovary syndrome and breast cancer subtypes: a Mendelian randomization study.","volume":"225","author":"Zhu","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20260904","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13048-023-01306-y","article-title":"Causal pathways linking polycystic ovary syndrome to distinct breast cancer subtypes using multivariable Mendelian randomization analysis.","volume":"16","author":"Cao","year":"2023","journal-title":"J Ovarian Res"},{"key":"R8-20260904","first-page":"892528654","article-title":"An update on polycystic ovary syndrome: a review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options.","volume":"18","author":"Islam","year":"2022","journal-title":"Womens Health"},{"key":"R9-20260904","doi-asserted-by":"crossref","first-page":"1120119","DOI":"10.3389\/fendo.2023.1120119","article-title":"Causal relationship between polycystic ovary syndrome and chronic kidney disease: a Mendelian randomization study.","volume":"14","author":"Du","year":"2023","journal-title":"Front Endocrinol"},{"key":"R10-20260904","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1093\/ndt\/gfad082","article-title":"The incidence and prevalence of IgA nephropathy in Europe.","volume":"38","author":"Willey","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"R11-20260904","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.2147\/IJGM.S530953","article-title":"Identification and validation of aging-related genes in IgA nephropathy in the Asian Population.","volume":"18","author":"Shu","year":"2025","journal-title":"Int J Gen Med"},{"key":"R12-20260904","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.semnephrol.2018.05.013","article-title":"Epidemiology of IgA nephropathy: a global perspective.","volume":"38","author":"Schena","year":"2018","journal-title":"Semin Nephrol"},{"key":"R13-20260904","doi-asserted-by":"crossref","first-page":"11462","DOI":"10.7150\/thno.49778","article-title":"Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies.","volume":"10","author":"He","year":"2020","journal-title":"Theranostics"},{"key":"R14-20260904","doi-asserted-by":"crossref","first-page":"2458184","DOI":"10.1080\/19490976.2025.2458184","article-title":"Targeted modulation of intestinal barrier and mucosal immune-related microbiota attenuates IgA nephropathy progression.","volume":"17","author":"Zhang","year":"2025","journal-title":"Gut Microbes"},{"key":"R15-20260904","doi-asserted-by":"crossref","first-page":"e18258","DOI":"10.1111\/jcmm.18258","article-title":"Role of the gut microbiota and innate immunity in polycystic ovary syndrome: current updates and future prospects.","volume":"28","author":"Zhou","year":"2024","journal-title":"J Cell Mol Med"},{"key":"R16-20260904","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12874-022-01619-4","article-title":"Bayesian mendelian randomization with study heterogeneity and data partitioning for large studies.","volume":"22","author":"Zou","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"R17-20260904","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/0886022X.2021.1901739","article-title":"Estrogen and estrogen receptors in kidney diseases.","volume":"43","author":"Ma","year":"2021","journal-title":"Ren Fail"},{"key":"R18-20260904","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/ndt\/gfr369","article-title":"A candidate gene approach to genetic contributors to the development of IgA nephropathy.","volume":"27","author":"Yamamoto","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R19-20260904","doi-asserted-by":"crossref","first-page":"e21372","DOI":"10.1097\/MD.0000000000021372","article-title":"Identification of key genes and pathways in IgAN using bioinformatics analysis.","volume":"99","author":"Hu","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R20-20260904","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1080\/0886022X.2019.1635029","article-title":"Association between lifestyle, gender and risk for developing end-stage renal failure in IgA nephropathy: a case-control study within 10 years.","volume":"41","author":"Huang","year":"2019","journal-title":"Ren Fail"},{"key":"R21-20260904","doi-asserted-by":"crossref","first-page":"e13461","DOI":"10.14814\/phy2.13461","article-title":"Consequences of advanced aging on renal function in a chronic hyperandrogenemic female rat model: implications for aging women with polycystic ovary syndrome.","volume":"5","author":"Patil","year":"2017","journal-title":"Physiol Rep"},{"key":"R22-20260904","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/cen.14284","article-title":"Risk of chronic kidney disease among women with polycystic ovary syndrome: a long-term population-based cohort study.","volume":"93","author":"Behboudi-Gandevani","year":"2020","journal-title":"Clin Endocrinol"},{"key":"R23-20260904","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40360-023-00692-9","article-title":"Butyrate alleviates renal inflammation and fibrosis in a rat model of polycystic ovarian syndrome by suppression of SDF-1.","volume":"24","author":"Bashir","year":"2023","journal-title":"BMC Pharmacol Toxicol"},{"key":"R24-20260904","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1038\/s41401-023-01128-0","article-title":"Serum granulosa cell-derived TNF-\u03b1promotes inflammation and apoptosis of renal tubular cells and PCOS-related kidney injury through NF-\u03baB signaling.","volume":"44","author":"Ye","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"R25-20260904","first-page":"176","article-title":"Association of glomerular filtration rate with inflammation in polycystic ovary syndrome.","volume":"9","author":"Gozukara","year":"2015","journal-title":"Int J Fertil Steril"},{"key":"R26-20260904","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.fertnstert.2008.12.120","article-title":"Predictors of urinary albumin excretion in patients with polycystic ovary syndrome.","volume":"93","author":"Duleba","year":"2010","journal-title":"Fertil Steril"},{"key":"R27-20260904","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2019.01.048","article-title":"Immunophenotypic profile of leukocytes in hyperandrogenemic female rats, an animal model of polycystic ovary syndrome.","volume":"220","author":"Moulana","year":"2019","journal-title":"Life Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:00:58Z","timestamp":1788530458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":27,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048704","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"2025-08-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}